Examination Report |
1 | Reply to Exam Report (MIS-R) | 05 Aug 2015 |
2 | Journal Copy | 05 May 2018 |
3 | TM-O(NOTICE OF OPPOSITION) | 12 Jul 2018 |
4 | TM-O(NOTICE OF OPPOSITION) | 16 Jul 2018 |
5 | TM-O(NOTICE OF OPPOSITION) | 17 Jul 2018 |
6 | Letter of Withdrawal | 17 Oct 2018 |
7 | TM-1 |
1 | Hearing Notice (Show Cause) | 5813138 | 2624952 | 02 Feb 2018 |
2 | Tribunal Accepted Notice for : 2693143 | 6011537 | 2721477 | 07 Mar 2018 |
3 | Opposition Notice | 7022912 | 3233769 | 21 Sep 2018 |
4 | Opposition Notice | 7103823 | 3282405 | 08 Oct 2018 |
5 | Opposition Notice | 7119127 | 3300088 | 10 Oct 2018 |
6 | Order Form of 21(2) | 15940308 | 6164119 | 31 Aug 2023 |
7 | Order Form of 21(2) | 15940311 | 6164105 | 31 Aug 2023 |
Trademark was applied on 06 March 2014 with IP India.
Proprietor of Erimicin is BLISS GVS PHARMA.
Class(es) in which the trademark was applied to is 5.
Status of Erimicin is Abandoned.
Application number alloted to the trademark is 2693143.
H. P. Associates is the Trademark agent/attorney.
Trademark has been filed in the following category:
DEVICE